Novo Nordisk Fonden financials

Novo Nordisk Fonden

Country: DK Reporting currency: DKK Latest annual report: 2025-12-31

LEI: 529900UTAHSVRYZL0380

Financial statements (DKK, as reported — unscaled; 104 line items across 2 annual periods)

Line item	2025	2024
Income statement
Revenue	DKK 384.72B	DKK 342.80B
Cost of sales	DKK 105.14B	DKK 76.11B
Gross profit	DKK 279.58B	DKK 266.68B
Administrative expenses	DKK 14.23B	DKK 9.83B
Operating profit (EBIT)	DKK 132.58B	DKK 146.27B
Finance costs	DKK 14.09B	DKK 11.31B
Profit before tax	DKK 133.39B	DKK 153.25B
Income tax expense	DKK 29.07B	DKK 27.08B
Profit for the year	DKK 104.32B	DKK 126.17B
— attributable to owners	DKK 27.98B	DKK 52.05B
— attributable to NCI	DKK 76.34B	DKK 74.12B
Total comprehensive income	DKK 98.76B	DKK 124.36B
Cash flow statement
Net cash from operating activities	DKK 120.88B	DKK 130.81B
Income taxes paid	DKK 43.36B	DKK 32.05B
Net cash from investing activities	-DKK 104.79B	-DKK 161.82B
Purchase of intangibles	DKK 30.49B	DKK 4.44B
Net cash from financing activities	-DKK 13.76B	DKK 48.69B
Dividends paid	DKK 40.32B	DKK 33.70B
Proceeds from borrowings	DKK 123.21B	DKK 120.36B
Repayments of borrowings	DKK 86.60B	DKK 16.95B
Lease liability payments	DKK 625.0M	DKK 365.0M
Net change in cash	DKK 2.33B	DKK 17.67B
Balance sheet
Total assets	DKK 955.47B	DKK 883.42B
Non-current assets	DKK 740.31B	DKK 666.05B
Property, plant & equipment	DKK 255.50B	DKK 212.48B
Current assets	DKK 215.16B	DKK 217.37B
Inventories	DKK 60.69B	DKK 52.26B
Trade & other receivables	DKK 82.78B	DKK 85.77B
Cash & equivalents	DKK 39.30B	DKK 37.25B
Total equity	DKK 458.58B	DKK 411.23B
— attributable to owners	DKK 245.28B	DKK 231.53B
Non-controlling interests	DKK 213.29B	DKK 179.70B
Non-current liabilities	DKK 238.69B	DKK 214.59B
Long-term borrowings	DKK 195.59B	DKK 172.31B
Current liabilities	DKK 258.20B	DKK 257.60B
Deferred tax liabilities	DKK 10.82B	DKK 10.57B
Derived metrics
Operating margin	34.5%	42.7%
Net margin	27.1%	36.8%
Return on equity	22.7%	30.7%
Cash conversion ratio	1.16×	1.04×
Other reported items
Adjustments For Decrease Increase In Inventories	-DKK 9.13B	-DKK 7.71B
Adjustments For Decrease Increase In Trade and Other Receivables	-DKK 1.98B	-DKK 16.34B
Adjustments For Depreciation and Amortisation Expense and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss	DKK 36.21B	DKK 25.66B
Adjustments For Increase Decrease In Trade and Other Payables	DKK 5.20B	DKK 14.73B
Adjustments For Unrealised Foreign Exchange Losses Gains	DKK 7.50B	DKK 1.38B
Cash	DKK 39.30B	DKK 37.25B
Cash Flows From Used In Operations Before Changes In Working Capital	DKK 119.30B	DKK 138.76B
Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities	DKK 12.92B	DKK 124.29B
Comprehensive Income Attributable To Noncontrolling Interests	DKK 73.19B	DKK 73.06B
Comprehensive Income Attributable To Owners of Parent	DKK 25.57B	DKK 51.29B
Current Borrowings and Current Portion of Noncurrent Borrowings	DKK 26.42B	DKK 15.73B
Current Contract Assets	DKK 1.17B	DKK 3.57B
Current Contract Liabilities	DKK 195.0M	DKK 1.71B
Current Derivative Financial Assets	DKK 6.85B	DKK 6.36B
Current Derivative Financial Liabilities	DKK 2.06B	DKK 7.78B
Current Financial Assets At Fair Value Through Profit Or Loss	DKK 677.0M	DKK 10.65B
Current Tax Assets Current	DKK 6.38B	DKK 3.79B
Current Tax Liabilities Current	DKK 9.50B	DKK 21.54B
Decrease Increase Through Tax On Sharebased Payment Transactions	-DKK 59.0M	-DKK 809.0M
Deferred Tax Assets	DKK 12.37B	DKK 14.62B
Dividends Paid To Noncontrolling Interests Classified As Financing Activities	DKK 40.32B	DKK 33.70B
Effect of Exchange Rate Changes On Cash and Cash Equivalents	-DKK 389.0M	DKK 498.0M
Equity and Liabilities	DKK 955.47B	DKK 883.42B
Finance Costs Paid Classified As Operating Activities	DKK 4.29B	DKK 5.22B
Finance Income	DKK 10.57B	DKK 6.76B
Finance Income Received Classified As Operating Activities	DKK 1.81B	DKK 2.40B
Gains Losses On Cash Flow Hedges Before Tax	DKK 4.56B	-DKK 4.69B
Income Tax Relating To Components of Other Comprehensive Income	DKK 2.67B	-DKK 1.37B
Increase Decrease Through Acquisition of Subsidiary	-DKK 143.0M	DKK 54.02B
Increase Decrease Through Changes In Ownership Interests In Subsidiaries That Do Not Result In Loss of Control	DKK 0	-DKK 3.19B
Increase Decrease Through Sharebased Payment Transactions	DKK 1.62B	DKK 2.46B
Intangible Assets Other Than Goodwill	DKK 273.81B	DKK 255.53B
Investment Property	DKK 26.28B	DKK 25.46B
Investments In Associates Accounted For Using Equity Method	DKK 1.29B	DKK 7.45B
Issued Capital	DKK 22.0M	DKK 22.0M
Liabilities	DKK 496.90B	DKK 472.19B
Noncurrent Assets Or Disposal Groups Classified As Held For Sale	DKK 0	DKK 87.0M
Noncurrent Financial Assets	DKK 171.07B	DKK 150.50B
Other Adjustments For Noncash Items	-DKK 3.65B	DKK 1.70B
Other Comprehensive Income	-DKK 5.56B	-DKK 1.82B
Other Comprehensive Income Before Tax Exchange Differences On Translation	-DKK 14.58B	DKK 3.58B
Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans	DKK 25.0M	-DKK 120.0M
Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Before Tax	DKK 1.33B	-DKK 123.0M
Other Current Liabilities	DKK 50.88B	DKK 46.23B
Other Expense By Function	DKK 14.00B	DKK 8.28B
Other Longterm Provisions	DKK 7.51B	DKK 9.21B
Other Noncurrent Liabilities	DKK 5.69B	DKK 4.91B
Other Reserves	-DKK 2.99B	-DKK 409.0M
Other Shortterm Provisions	DKK 1.20B	DKK 485.0M
Payments From Changes In Ownership Interests In Subsidiaries	DKK 0	DKK 3.98B
Payments To Acquire Or Redeem Entitys Shares	DKK 2.13B	DKK 10.02B
Proceeds From Sale Or Issue of Treasury Shares	DKK 332.0M	DKK 282.0M
Proceeds From Sales of Investments Other Than Investments Accounted For Using Equity Method	DKK 10.65B	DKK 24.39B
Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities	DKK 148.0M	DKK 191.0M
Proceeds From Sales Or Maturity of Financial Assets Measured At Fair Value Through Profit Or Loss Classified As Investing Activities	DKK 18.98B	DKK 8.87B
Purchase of Financial Assets Measured At Fair Value Through Profit Or Loss Classified As Investing Activities	DKK 11.53B	DKK 9.61B
Purchase of Investments Other Than Investments Accounted For Using Equity Method	DKK 498.0M	DKK 19.03B
Purchase of Treasury Shares	DKK 2.13B	DKK 10.02B
Reclassification Adjustments On Cash Flow Hedges Before Tax	-DKK 5.78B	DKK 1.83B
Research and Development Expense	DKK 55.85B	DKK 52.07B
Retained Earnings	DKK 233.25B	DKK 216.91B
Sale Or Issue of Treasury Shares	DKK 332.0M	DKK 282.0M
Share of Profit Loss of Associates Accounted For Using Equity Method	DKK 4.33B	DKK 11.53B
Trade and Other Current Payables To Trade Suppliers	DKK 25.73B	DKK 36.38B

Methodology

Every line item above is a fact tagged in Novo Nordisk Fonden's annual report filed in the European Single Electronic Format (ESEF) under the IFRS taxonomy (ifrs-full) — the income statement, balance sheet and cash-flow statement as the filer reported them. Values are shown as-is, in the reporting currency (DKK), without rescaling; the row labels map to the underlying concept name (e.g. Revenue → ifrs-full:Revenue, Operating profit → ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS → ifrs-full:DilutedEarningsLossPerShare), and any concept without a curated label is shown under “Other reported items” with its de-camel-cased tag name. Only consolidated, default-member facts are shown (segment / dimensional breakdowns are excluded).

“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.

Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.